Blas Frangione,Einar M. Sigurdsson,Thomas Wisniewski,Jorge Ghiso
申请号：
US13655234
公开号：
US09409146B2
申请日:
2012.10.18
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Disclosed herein are methods for treating amyloid disease in humans by clearing amyloid peptides from one or more bodily fluids such as, e.g., blood, of a patient. In particular, the methods are based on the administration of compounds capable of binding to amyloid-beta (Aβ) or on dialysis of blood or plasma exchange in order to remove Aβ peptides from the blood circulation, and/or brain or other affected organs.
